Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 28 (7), 841-5

Association of Antiphosphatidylserine/Prothrombin Antibodies With Neuropsychiatric Systemic Lupus Erythematosus

Affiliations

Association of Antiphosphatidylserine/Prothrombin Antibodies With Neuropsychiatric Systemic Lupus Erythematosus

Tomoko Syuto et al. Clin Rheumatol.

Abstract

Neuropsychiatric manifestations in patients with systemic lupus erythematosus (SLE) are well-recognized symptoms although the pathophysiology of neuropsychiatric SLE (NPSLE) is unclear. Since an association with antiphospholipid antibodies has been reported, we examined the prevalence of antiphosphatidylserine-prothrombin antibodies (anti-PS/PT Abs), lupus anticoagulant (LA), anticardiolipin/beta2-glycoprotein I antibodies (anti-beta2-GPI Abs), and antiribosomal P protein antibodies (antiribosomal P Abs) in 68 SLE patients and analyzed their associations with neuropsychiatric manifestations. The prevalence of LA was significantly higher in the patients with neuropsychiatric (NP) features than those without NP features (P < 0.02). The levels of anti-PS/PT antibody were also significantly higher in the patients with NP features than those without NP features (P < 0.01). The results indicate that LA positivity and higher levels of anti-PS/PT antibody can be predictive markers for NPSLE.

Similar articles

See all similar articles

Cited by 5 PubMed Central articles

References

    1. Semin Arthritis Rheum. 2007 Apr;36(5):297-315 - PubMed
    1. J Rheumatol. 2004 Nov;31(11):2156-62 - PubMed
    1. Arthritis Rheum. 2008 Feb 15;59(2):206-13 - PubMed
    1. J Rheumatol. 2002 Jul;29(7):1536-42 - PubMed
    1. Rheumatology (Oxford). 2008 May;47(5):684-9 - PubMed

MeSH terms

Feedback